ANALYSIS OF NON-INVASIVE LIVER BIOMARKERS IN A PHASE I I TRIAL OF THE GLUCAGON AND GLP-1 RECEPTOR DUAL AGONIST SURVODUTIDE IN PEOPLE WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND FIBROSIS
HEPATOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined